The effect of Melissa officinalis on Female sexual desire
- Conditions
- female sexual dysfunction.Sexual dysfunction, not caused by organic disorder or disease
- Registration Number
- IRCT2014021516580N1
- Lead Sponsor
- Vice chancellor for research of Shahed University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 38
Inclusion criteria : Women ages 18-50 years; Diagnosis low sexual desire by using the FSFI ( Female Sexual Function Index ); Emotionally satisfying relationship with constant wife sexually active at least one year; Having sex at least once a month; Lack of pregnancy and lactation; No menstruation retard for 2 months and more ; Normal genital examination. Exclusion criteria : Impaired emotionally satisfying relationship with wife ; Adding another partner in the study period; Any organic disease, anatomical and hormonal that exist in history and past medical history, including : diabetes , cerebrovascular disease , liver and kidney damage , heart disease , hypothyroidism, cancer; Psychiatric disorders who are under medical treatment; Smoking , alcohol , drug abuse; Use of any chemical and herbal medications that affect sexual desire.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sexual desire. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Questionnaire Female Sexual Function Index.
- Secondary Outcome Measures
Name Time Method Sexual arousal. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Questionnaire Female Sexual Function Index.;Sexual Satisfaction. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Questionnaire Female Sexual Function Index.;Obvious distress caused by sexual dysfunction. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Question of patients.;Painful intercourse. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Questionnaire Female Sexual Function Index.;Moisture of genitalia. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Questionnaire Female Sexual Function Index.;Increased frequency of sexual intercourse. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Question of patients.